No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16213744 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Monika Bidzan-Wiącek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioenergetics and Physiology of Exercise, Medical University of Gdansk, 80-210 Gdansk, Poland. Hauptthemen laut MEDLINE: Kynurenine, Fatty Acids, Omega-3, Depression, Dietary Supplements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Narodowe Centrum Nauki.
Themen: Depression
Abstract (Originalsprache)
Background
Increased inflammation and heightened physiological stress reactivity have been associated with pathophysiology of depressive symptoms. The underlying biological mechanisms by which inflammation and stress may influence neurogenesis are changes in the kynurenine (KYN) pathway, which is activated under stress. Supplementation with n-3 polyunsaturated fatty acids (n-3 PUFAs) has anti-inflammatory properties and can increase stress resilience. Whether n-3 PUFAs alter KYN stress response is unknown.
Objectives
This placebo-controlled study investigated the effect of n-3 PUFAs on KYN metabolism, inflammation, depressive symptoms, and mood. Moreover, stress-induced changes following a laboratory stressor have been assessed.
Methods
In this placebo-controlled study, 47 healthy male adults received either 4 g n-3 PUFAs per day (Omega-3 group) or a placebo (Placebo group) for 12 weeks.
Results
A significant group-by-time interaction was found for the inflammatory markers gp130 (F = 7.07, p = 0.011), IL-6R alpha (F = 10.33, p = 0.003), and TNF_RI (F= 10.92, p = 0.002). No significant group-by-time interactions were found for KYN metabolites, depressive symptoms, and mood (except for Hedonic tone (F = 6.50, p = 0.014)), nor for stress-induced changes in KYN metabolites and mood following a laboratory stressor.
Conclusions
Overall, increased n-3 PUFA levels in healthy men ameliorate inflammatory markers but do not ameliorate KYN metabolism, depressive symptoms, mood, or KYN metabolism and mood following a stress induction. This study was registered at ClinicalTrials.gov with the identifier NCT05520437 (30/08/2022 first trial registration).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioenergetics and Physiology of Exercise, Medical University of Gdansk, 80-210 Gdansk, Poland.
- Department of Biochemistry, University of Physical Education and Sport, 80-336 Gdansk, Poland.
- Department of Quality of Life Research, Medical University of Gdansk, 80-210 Gdansk, Poland.
- Department of Environmental Analytics, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland.
- Department of Pharmaceutical Biochemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.
ORCID-Profile: Magdalena Błażek, Adriana Mika
Förderung
- National Science Center
- Narodowe Centrum Nauki
Zitieren
APA
Bidzan-Wiącek, M., Tomczyk, M., Błażek, M., Mika, A., & Antosiewicz, J. (2024). No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu16213744
Vancouver
Bidzan-Wiącek M, Tomczyk M, Błażek M, Mika A, Antosiewicz J. No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial. Nutrients. 2024. doi:10.3390/nu16213744
BibTeX
@article{BidzanWicek2024,
author = {Bidzan-Wiącek, Monika and Tomczyk, Maja and Błażek, Magdalena and Mika, Adriana and Antosiewicz, Jędrzej},
title = {No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16213744}
}
EUVIMED